The mother of two autistic children in France has lodged a legal complaint for endangering life after she suspected she was exposed to airborne emissions from Sanofi's Depakine epilepsy drug plant, the Le Monde newspaper reported on Monday. Melanie S., whose children showed neuro-developmental disorders similar to those observed in children whose mothers took Depakine during pregnancy, has never used the drug but since 2011 she has worked in an office located some 50 metres from the plant in Mourenx, southwest France, the paper said.
The prevalence of Epilepsy has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of Epilepsy and the growing research and
/PRNewswire/ DelveInsight s Epilepsy Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline epilepsy.